Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2022-01-05 00:00:00 ET · period of report 2022-01-03 · accession 0001209191-22-001743 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-05 | 2022-01-03 | KYNB | Eisner Mark | Chief Medical Off | F - Tax | $14.82 | -7,043 | 98.1K | -7% | -$104.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-03 | F | D | 7,043 | $14.82 | 98,139 | D | — | — | (F1) Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. |